EP3601239

NÝJAR HETERÓSÝKLÍSKAR AFLEIÐUR SEM ERU GAGNLEGAR SEM SHP2 HEMLAR

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    23.3.2018
  • EP published:
    31.7.2024
  • EP application number:
    18770877.1
  • Max expiry date:
    22.3.2038
  • Expiry date:
    22.3.2027
  • Next due date:
    31.3.2027
  • Title in English:
    NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS
  • Language of the patent:
    English

Timeline

Today
23.3.2018EP application
31.7.2024EP Publication
13.9.2024Translation submitted
15.10.2024Registration published
22.3.2027Expires

Owner

  • Name:
    Jacobio Pharmaceuticals Co., Ltd.
  • Address:
    Unit 2, Building 5, BYBP No.88 Kechuang Street 6th Business Development Area Daxing, Beijing 101111, CN

Inventor

  • Name:
    MA, Cunbo
  • Address:
    Beijing 101111, CN
  • Name:
    GAO, Panliang
  • Address:
    Beijing 101111, CN
  • Name:
    HU, Shaojing
  • Address:
    Beijing 101111, CN
  • Name:
    XU, Zilong
  • Address:
    Beijing 101111, CN
  • Name:
    HAN, Huifeng
  • Address:
    Beijing 101111, CN
  • Name:
    WU, Xinping
  • Address:
    Beijing 101111, CN
  • Name:
    KANG, Di
  • Address:
    Beijing 101111, CN

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105, Reykjavík,

Priority

  • Number:
    PCT/IB2017/051690
  • Date:
    23.3.2017
  • Country:
    WO

Classification

  • Categories:
    C07D 401/14, C07D 491/107, C07D 495/10, C07D 471/20, A61K 31/497, A61P 35/00, C07D 405/14, C07D 491/113, C07D 491/20, C07D 513/10, C07F 9/6558, C07D 471/10

Annual fees

Number

Paid

Expires

Payer

Number: 8

Paid: 18.3.2025

Expires: 22.3.2026

Payer: Árnason Faktor ehf.

Number: 9

Paid: 27.3.2026

Expires: 22.3.2027

Payer: Árnason Faktor ehf.

Upload documents